Figures & data
Table 1. Association between common genetic variants of the vitamin D binding protein gene (GC) and various diseases.
Abbas S, Linseisen J, Slanger T, et al. The Gc2 allele of the vitamin D binding protein is associated with a decreased postmenopausal breast cancer risk, independent of the vitamin D status. Cancer Epidemiol Biomarkers Prev 2008;17:1339–43 Anderson LN, Cotterchio M, Cole DE, Knight JA. Vitamin D-related genetic variants, interactions with vitamin D exposure, and breast cancer risk among Caucasian women in Ontario. Cancer Epidemiol Biomarkers Prev 2011;20:1708–17 McCullough ML, Stevens VL, Diver WR, et al. Vitamin D pathway gene polymorphisms, diet, and risk of postmenopausal breast cancer: a nested case-control study. Breast Cancer Res 2007;9:R9 Hibler EA, Hu C, Jurutka PW, et al. Polymorphic variation in the GC and CASR genes and associations with vitamin D metabolite concentration and metachronous colorectal neoplasia. Cancer Epidemiol Biomarkers Prev 2012;21:368–75 Poynter JN, Jacobs ET, Figueiredo JC, et al. Genetic variation in the vitamin D receptor (VDR) and the vitamin D-binding protein (GC) and risk for colorectal cancer: results from the Colon Cancer Family Registry. Cancer Epidemiol Biomarkers Prev 2010;19:525–36 Zhou L, Zhang X, Chen X, et al. GC Glu416Asp and Thr420Lys polymorphisms contribute to gastrointestinal cancer susceptibility in a Chinese population. Int J Clin Exp Med 2012;5:72–9 Ahn J, Albanes D, Berndt SI, et al. Vitamin D-related genes, serum vitamin D concentrations and prostate cancer risk. Carcinogenesis 2009;30:769–76 Corder EH, Friedman GD, Vogelman JH, Orentreich N. Seasonal variation in vitamin D, vitamin D-binding protein, and dehydroepiandrosterone: risk of prostate cancer in black and white men. Cancer Epidemiol Biomarkers Prev 1995;4:655–9 Dimopoulos MA, Germenis A, Savides P, et al. Genetic markers in carcinoma of the prostate. Eur Urol 1984;10:315–16 Flohil SC, De Vries E, Van Meurs JBJ, et al. Vitamin D-binding protein polymorphisms are not associated with development of (multiple) basal cell carcinomas. Exp Dermat 2010;19:1103–5 Wjst M, Altmuller J, Faus-Kessler T, et al. Asthma families show transmission disequilibrium of gene variants in the vitamin D metabolism and signalling pathway. Respir Res 2006;7:60 Li F, Jiang L, Willis-Owen SA, et al. Vitamin D binding protein variants associate with asthma susceptibility in the Chinese Han population. BMC Med Genet 2011;12:103 Horne SL, Cockcroft DW, Dosman JA. Possible protective effect against chronic obstructive airways disease by the GC2 allele. Hum Hered 1990;40:173–6 Ito I, Nagai S, Hoshino Y, et al. Risk and severity of COPD is associated with the group-specific component of serum globulin 1F allele. Chest 2004;125:63–70 Janssens W, Bouillon R, Claes B, et al. Vitamin D deficiency is highly prevalent in COPD and correlates with variants in the vitamin D-binding gene. Thorax 2010;65:215–20 Kasuga I, Pare PD, Ruan J, et al. Lack of association of group specific component haplotypes with lung function in smokers. Thorax 2003;58:790–3 Kueppers F, Miller RD, Gordon H, et al. Familial prevalence of chronic obstructive pulmonary disease in a matched pair study. Am J Med 1977;63:336–42 Schellenberg D, Pare PD, Weir TD, et al. Vitamin D binding protein variants and the risk of COPD. Am J Respir Crit Care Med 1998;157:957–61 Shen LH, Zhang XM, Su DJ, et al. Association of vitamin D binding protein variants with susceptibility to chronic obstructive pulmonary disease. J Int Med Res 2010;38:1093–8 Wood AM, Bassford C, Webster D, et al. Vitamin D-binding protein contributes to COPD by activation of alveolar macrophages. Thorax 2011;66:205–10 Cooper JD, Smyth DJ, Walker NM, et al. Inherited variation in vitamin d genes is associated with predisposition to autoimmune disease type 1 diabetes. Diabetes 2011;60:1624–31 Hodge SE, Anderson CE, Neiswanger K, et al. Association studies between Type 1 (insulin-dependent) diabetes and 27 genetic markers: lack of association between Type 1 diabetes and Kidd blood group. Diabetologia 1983;25:343–7 Pani MA, Donner H, Herwig J, et al. Vitamin D binding protein alleles and susceptibility for type 1 diabetes in Germans. Autoimmunity 1999;31:67–72 Baier LJ, Dobberfuhl AM, Pratley RE, et al. Variations in the vitamin D-binding protein (Gc locus) are associated with oral glucose tolerance in nondiabetic Pima Indians. J Clin Endocrinol Metab 1998;83:2993–96 Hirai M, Suzuki S, Hinokio Y, et al. Group specific component protein genotype is associated with NIDDM in Japan. Diabetologia 1998;41:742–3 Hirai M, Suzuki S, Hinokio Y, et al. Variations in vitamin D-binding protein (group-specific component protein) are associated with fasting plasma insulin levels in Japanese with normal glucose tolerance. J Clin Endocrinol Metab 2000;85:1951–53 Iyengar S, Hamman RF, Marshall JA, et al. On the role of vitamin D binding globulin in glucose homeostasis: results from the San Luis Valley Diabetes Study. Genet Epidemiol 1989;6:691–8 Klupa T, Malecki M, Hanna L, et al. Amino acid variants of the vitamin D-binding protein and risk of diabetes in white Americans of European origin. Eur J Endocrinol 1999;141:490–93 Malecki MT, Klupa T, Wanic K, et al. Vitamin D binding protein gene and genetic susceptibility to type 2 diabetes mellitus in a Polish population. Diabetes Res Clin Pract 2002;57:99–104 Szathmary EJ. The effect of Gc genotype on fasting insulin level in Dogrib Indians. Hum Genet 1987;75:368–72 Ye WZ, Dubois-Laforgue D, Bellanne-Chantelot C, et al. Variations in the vitamin D-binding protein (Gc locus) and risk of type 2 diabetes mellitus in French Caucasians. Metabolism 2001;50:366–69 Faserl K, Golderer G, Kremser L, et al. Polymorphism in vitamin D-binding protein as a genetic risk factor in the pathogenesis of endometriosis. J Clin Endocrinol Metab 2011;96:E233–41 Kurylowicz A, Ramos-Lopez E, Bednarczuk T, Badenhoop K. Vitamin D-binding protein (DBP) gene polymorphism is associated with Graves' disease and the vitamin D status in a Polish population study. Exp Clin Endocrinol Diabetes 2006;114:329–35 Pani MA, Regulla K, Segni M, et al. A polymorphism within the vitamin D-binding protein gene is associated with Graves' disease but not with Hashimoto's thyroiditis. J Clin Endocrinol Metab 2002;87:2564–7 Wang X, Cheng S, Brophy VH, et al. A meta-analysis of candidate gene polymorphisms and ischemic stroke in 6 study populations: association of lymphotoxin-alpha in nonhypertensive patients. Stroke 2009;40:683–95 Eloranta JJ, Wenger C, Mwinyi J, et al. Association of a common vitamin D-binding protein polymorphism with inflammatory bowel disease. Pharmacogenet Genomics 2011;21:559–64 Constans J, Arlet P, Viau M, Bouissou C. Unusual sialilation of the serum DBP associated with the Gc 1 allele in alcoholic cirrhosis of the liver. Clin Chim Acta 1983;130:219–30 Al oanzi ZH, Tuck SP, Mastana SS, et al. Vitamin D-binding protein gene microsatellite polymorphism influences BMD and risk of fractures in men. Osteoporos Int 2008;19:951–60 Eichner JE, Cauley JA, Ferrell RE, et al. Genetic variation in two bone-related proteins: is there an association with bone mineral density or skeletal size in postmenopausal women? Genet Epidemiol 1992;9:177–84 Ezura Y, Nakajima T, Kajita M, et al. Association of molecular variants, haplotypes, and linkage disequilibrium within the human vitamin D-binding protein (DBP) gene with postmenopausal bone mineral density. J Bone Miner Res 2003;18:1642–49 Fang Y, van Meurs JB, Arp P, et al. Vitamin D binding protein genotype and osteoporosis. Calcif Tissue Int 2009;85:85–93 Lauridsen AL, Vestergaard P, Hermann AP, et al. Female premenopausal fracture risk is associated with gc phenotype. J Bone Miner Res 2004;19:875–81 Papiha SS, Allcroft LC, Kanan RM, et al. Vitamin D binding protein gene in male osteoporosis: association of plasma DBP and bone mineral density with (TAAA)(n)-Alu polymorphism in DBP. Calcif Tissue Int 1999;65:262–6 Milman N, Thymann M, Graudal N, Morling N. Plasma vitamin D-binding protein (GC) factors, immunoglobulin G heavy chain (GM) allotypes and immunoglobulin kappa light chain (KM1) allotype in patients with sarcoidosis and in healthy control subjects. Sarcoidosis Vasc Diffuse Lung Dis 2002;19:97–100 Alonso A, Montesino M, Iturralde MJ, et al. GC subtyping and HIV infection in a Spanish population: no evidence of an association between GC subtypes and AIDS. Hum Hered 1990;40:34–7 Cleve H, Weidinger S, Gurtler LG, Deinhardt F. AIDS: no association with the genetic systems GC (D-binding protein), ORM (orosomucoid = alpha-1-acid glycoprotein), and A2HS (alpha-2-HS-glycoprotein). Infection 1988;16:31–5 Eales LJ, Nye KE, Parkin JM, et al. Association of different allelic forms of group specific component with susceptibility to and clinical manifestation of human immunodeficiency virus infection. Lancet 1987;1:999–1002 Pronk JC, Frants RR, Crusius B, et al. No predictive value of GC phenotypes for HIV infection and progression to AIDS. Hum Genet 1988;80:181–2 Putkonen P, Albert J, Karlsson A, et al. Group specific component and susceptibility to HIV infection and progression to AIDS. Scand J Infect Dis 1988;20:11–4 Rosberger DF, Werner PA, Steinman R, et al. Group specific component (Gc) and HIV diseases. Dis Markers 1988;6:269–74 Bahr GM, Eales LJ, Nye KE, et al. An association between Gc (vitamin D-binding protein) alleles and susceptibility to rheumatic fever. Immunology 1989;67:126–8 Martineau AR, Leandro AC, Anderson ST, et al. Association between Gc genotype and susceptibility to TB is dependent on vitamin D status. Eur Respir J 2010;35:1106–12 Palma AS, De Carvalho M, Grammel N, et al. Proteomic analysis of plasma from Portuguese patients with familial amyotrophic lateral sclerosis. Amyotroph Lateral Scler 2008;9:339–49 Hollsberg P, Haahr S, Larsen PM, Fey SJ. MS and the group-specific component. Acta Neurol Scand 1988;78:158–60 Lindblom B, Wetterling G, Link H. Distribution of group-specific component subtypes in multiple sclerosis. Acta Neurol Scand 1988;78:443–4 Niino M, Kikuchi S, Fukazawa T, et al. No association of vitamin D-binding protein gene polymorphisms in Japanese patients with MS. J Neuroimmunol 2002;127:177–9 Orton SM, Ramagopalan SV, Para AE, et al. Vitamin D metabolic pathway genes and risk of multiple sclerosis in Canadians. J Neurol Sci 2011;305:116–20 Simon KC, Munger KL, Xing Y, Ascherio A. Polymorphisms in vitamin D metabolism related genes and risk of multiple sclerosis. Mult Scler 2010;16:133–8 Steckley JL, Dyment DA, Sadovnick AD, et al. Genetic analysis of vitamin D related genes in Canadian multiple sclerosis patients. Canadian Collaborative Study Group. Neurology 2000;54:729–32 Suzuki M, Yoshioka M, Hashimoto M, et al. 25-Hydroxyvitamin D, vitamin D receptor gene polymorphisms, and severity of Parkinson's disease. Mov Disord 2012;27:264–71 Beckman L, Beckman G, Perris C. Gc serum groups and schizophrenia. Clin Genet 1980;17:149–52 Fananas L, Moral P, Marti Tusquets JL, Bertranpetit J. Genetic markers in schizophrenia: ACP1, ESD, TF and GC polymorphisms. Hum Hered 1990;40:136–40 Lange V. Genetic markers for schizophrenic subgroups. Psychiatr Clin (Basel) 1982;15:133–44 Papiha SS, Roberts DF, McLeish L. Group-specific component (Gc) subtypes and schizophrenia. Clin Genet 1982;22:321–6 Rudduck C, Franzen G, Hansson A, Rorsman B. Gc serum groups in schizophrenia. Hum Hered 1985;35:11–4 Saha N, Tsoi WF. Serum protein markers in Chinese schizophrenics–haptoglobin types and transferrin and group-specific component subtypes. Clin Genet 1990;37:54–8